HIV Vaccine

Known as: human immunodeficiency virus vaccine, HIV vaccines, HIV 
 
National Institutes of Health

Related topics

Related topics

3 relations
AIDS VaccinesAcquired Immunodeficiency Syndromehiv-infection/aids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
The development of stabilized recombinant HIV envelope trimers that mimic the virion surface molecule has increased enthusiasm… (More)
  • figure 2
  • figure 4
  • figure 5
  • figure 6
  • figure 7
Is this relevant?
Review
2015
Review
2015
Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection.
RV144 remains the only HIV-1 vaccine trial to demonstrate efficacy against HIV-1 acquisition. The prespecified analysis of immune… (More)
  • table 1
  • figure 1
Is this relevant?
2015
2015
Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides.
An HIV vaccine capable of inducing high and durable levels of broadly neutralizing antibodies has thus far proven elusive. A… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Superior Control of HIV-1 Replication by CD8+ T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design
A successful HIV vaccine will likely induce both humoral and cell-mediated immunity, however, the enormous diversity of HIV has… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Anti-HIV B Cell lines as candidate vaccine biosensors.
Challenge studies following passive immunization with neutralizing Abs suggest that an HIV vaccine could be efficacious were it… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
  • table II
Is this relevant?
2011
2011
Sublingual administration of an adenovirus serotype 5 (Ad5)-based vaccine confirms Toll-like receptor agonist activity in the oral cavity and elicits improved mucosal and systemic cell-mediated…
HIV/AIDS continue to devastate populations worldwide. Recent studies suggest that vaccines that induce beneficial immune… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2006
Review
2006
Combination DNA plus protein HIV vaccines
  • Shan Lu
  • Springer Seminars in Immunopathology
  • 2006
A major challenge in developing an HIV vaccine is to identify immunogens and delivery methods that will elicit balanced humoral… (More)
Is this relevant?
2005
2005
Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques.
Adenovirus 5 (Ad5) vectors show promise as human immunodeficiency virus vaccine candidates. Indian rhesus macaques vaccinated… (More)
Is this relevant?
2002
2002
Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells.
Preclinical data are reported that support a human immunodeficiency virus (HIV) vaccine strategy using recombinant canarypox-HIV… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1998
1998
Attitudes about human immunodeficiency virus immunization: the influence of health beliefs and vaccine characteristics.
BACKGROUND AND OBJECTIVES The development of a vaccine to prevent human immunodeficiency virus (HIV) infection is a highly… (More)
Is this relevant?